Related Experiment Videos
Monocyte adhesion to fibronectin in psoriasis
G Rein1, A Abraham, S P Raychadauri
1Psoriasis Research Institute, Palo Alto, California 94301.
International Journal of Dermatology
|May 1, 1994
Summary
Substance P may contribute to new psoriasis lesions in unstable cases, but monocyte adhesion to fibronectin isn't a key factor in chronic psoriasis. This study explored monocyte adhesion in psoriasis patients.
Area of Science:
- Immunology
- Dermatology
- Cell Biology
Background:
- Mononuclear cells (MNC) differentiate into macrophages after extravasation, involving chemotaxis and adhesion to extracellular matrix proteins.
- Endothelial adhesion and chemotaxis are altered in psoriasis, but MNC adhesion to extracellular matrix proteins remains unstudied.
- Transforming growth factor-beta (TGF-beta) abnormally regulates MNC adhesion to endothelial cells in psoriasis.
Purpose of the Study:
- To investigate the role of substance P in regulating monocyte adhesion to fibronectin in psoriasis.
- To test the hypothesis that substance P influences monocyte-fibronectin interactions in psoriatic individuals.
Main Methods:
- Monocytes were isolated from 16 healthy controls and 11 psoriatic patients using gradient centrifugation.
- Monocyte adhesion to fibronectin was assessed using fibronectin-coated microtiter plates.
- Adherent cell numbers were quantified by measuring hexosaminidase activity.
Main Results:
- No significant differences in basal or substance P-stimulated monocyte adhesion were found between normal and psoriatic individuals.
- A subset of psoriatic patients showed a response to substance P.
- This in vitro response correlated with unstable psoriasis linked to stressful life events.
Conclusions:
- Monocyte priming by fibronectin or substance P is not critical in the pathogenesis of stable, chronic psoriasis.
- Substance P may play a role in the development of new lesions in some patients with unstable psoriasis.
- The findings suggest a potential link between substance P, monocyte behavior, and the exacerbation of psoriasis in specific patient subgroups.